Toussaint, Marie
Jackson, David J
Swieboda, Dawid
Guedán, Anabel
Tsourouktsoglou, Theodora-Dorita
Ching, Yee Man
Radermecker, Coraline
Makrinioti, Heidi
Aniscenko, Julia
Bartlett, Nathan W
Edwards, Michael R
Solari, Roberto
Farnir, Frédéric
Papayannopoulos, Venizelos
Bureau, Fabrice
Marichal, Thomas http://orcid.org/0000-0003-1688-6291
Johnston, Sebastian L http://orcid.org/0000-0003-3009-9200
Article History
Received: 28 November 2016
Accepted: 4 April 2017
First Online: 1 May 2017
Change Date: 12 July 2017
Change Type: Corrigendum
Change Details: In the version of this article initially published, Dr. Nathan W Bartlett was inadvertently omitted from the author list and the Contributions section. The errors have been corrected in the HTML and PDF versions of the article.
Competing interests
: D.J.J. has received support for travel expenses to attend Respiratory Conferences from AstraZeneca, Boehringer Ingelheim (UK) and GSK. S.L.J. reports grants and/or personal fees from Centocor; Sanofi Pasteur; GSK; Chiesi; Boehringer Ingelheim; Novartis; grants, personal fees and shareholding from Synairgen; personal fees from Bioforce outside the submitted work; In addition, S.L.J. is involved in patents relating to use of interferon-β and interferon-λ for the treatment and prevention of virally induced exacerbation in asthma and chronic pulmonary obstructive disease, and for the induction of cross-reactive cellular responses against rhinovirus antigens.